Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challenges.

Nixon, N A; Blais, N; Ernst, S; Kollmannsberger, C; Bebb, G; Butler, M; Smylie, M; Verma, S

Nixon, N A; Blais, N; Ernst, S; Kollmannsberger, C; Bebb, G; Butler, M; Smylie, M; Verma, S.

Afiliação

Nixon NA; Tom Baker Cancer Centre, Calgary, AB.
Blais N; chum-Hôpital Notre-Dame, Montreal, QC.
Ernst S; London Health Sciences Centre, London, ON.
Kollmannsberger C; BC Cancer, Vancouver, BC.
Bebb G; Tom Baker Cancer Centre, Calgary, AB.
Butler M; University Health Network, Princess Margaret Hospital, Toronto, ON.
Smylie M; Cross Cancer Institute, Edmonton, AB.
Verma S; Tom Baker Cancer Centre, Calgary, AB.

Curr Oncol ; 25(5): e373-e384, 2018 10.

Article em En | MEDLINE | ID: mdl-30464687

Assuntos

Antineoplásicos Imunológicos/uso terapêutico; Imunoterapia; Neoplasias/terapia; Humanos

Palavras-chave

Immuno-oncology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Imunoterapia / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google